Hideaki Moteki1, Hela Azaiez2, Kevin T Booth2, Mitsuru Hattori3, Ai Sato4, Yoshihiko Sato4, Mitsuo Motobayashi5, Christina M Sloan2, Diana L Kolbe2, A Eliot Shearer2, Richard J H Smith2, Shin-Ichi Usami6. 1. Department of Otorhinolaryngology, Shinshu University School of Medicine, Matsumoto, Japan Department of Otolaryngology-Head and Neck Surgery, Molecular Otolaryngology & Renal Research Labs, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA Department of Hearing Implant Sciences, Shinshu University School of Medicine, Matsumoto, Japan. 2. Department of Otolaryngology-Head and Neck Surgery, Molecular Otolaryngology & Renal Research Labs, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA. 3. Department of Otorhinolaryngology, Shinshu University School of Medicine, Matsumoto, Japan. 4. Division of Diabetes, Endocrinology and Metabolism: Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan. 5. Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan. 6. Department of Otorhinolaryngology, Shinshu University School of Medicine, Matsumoto, Japan Department of Hearing Implant Sciences, Shinshu University School of Medicine, Matsumoto, Japan usami@shinshu-u.ac.jp.
Abstract
OBJECTIVES: We present a family with a mitochondrial DNA 3243A>G mutation resulting in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), of which some members have hearing loss in which a novel mutation in the P2RX2 gene was identified. METHODS: One hundred ninety-four (194) Japanese subjects from unrelated families were enrolled in the study. Targeted genomic enrichment and massively parallel sequencing of all known nonsyndromic hearing loss genes were performed to identify the genetic causes of hearing loss. RESULTS: A novel mutation in the P2RX2 gene that corresponded to c.601G>A (p.Asp201Tyr) was identified. Two patients carried the mutation and had severe sensorineural hearing loss, while other members with MELAS (who did not carry the P2RX2 mutation) had normal hearing. CONCLUSION: This is the first case report of a diagnosis of hearing loss caused by P2RX2 mutation in patients with MELAS. A potential explanation is that a decrease in adenosine triphosphate (ATP) production due to MELAS with a mitochondrial 3243A>G mutation might suppress activation of P2X2 receptors. We also suggest that hearing loss caused by the P2RX2 mutation might be influenced by the decrease in ATP production due to MELAS.
OBJECTIVES: We present a family with a mitochondrial DNA 3243A>G mutation resulting in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), of which some members have hearing loss in which a novel mutation in the P2RX2 gene was identified. METHODS: One hundred ninety-four (194) Japanese subjects from unrelated families were enrolled in the study. Targeted genomic enrichment and massively parallel sequencing of all known nonsyndromic hearing loss genes were performed to identify the genetic causes of hearing loss. RESULTS: A novel mutation in the P2RX2 gene that corresponded to c.601G>A (p.Asp201Tyr) was identified. Two patients carried the mutation and had severe sensorineural hearing loss, while other members with MELAS (who did not carry the P2RX2 mutation) had normal hearing. CONCLUSION: This is the first case report of a diagnosis of hearing loss caused by P2RX2 mutation in patients with MELAS. A potential explanation is that a decrease in adenosine triphosphate (ATP) production due to MELAS with a mitochondrial 3243A>G mutation might suppress activation of P2X2 receptors. We also suggest that hearing loss caused by the P2RX2 mutation might be influenced by the decrease in ATP production due to MELAS.
Authors: G D Housley; R Kanjhan; N P Raybould; D Greenwood; S G Salih; L Järlebark; L D Burton; V C Setz; M B Cannell; C Soeller; D L Christie; S Usami; A Matsubara; H Yoshie; A F Ryan; P R Thorne Journal: J Neurosci Date: 1999-10-01 Impact factor: 6.167
Authors: S H Blanton; C Y Liang; M W Cai; A Pandya; L L Du; B Landa; S Mummalanni; K S Li; Z Y Chen; X N Qin; Y F Liu; T Balkany; W E Nance; X Z Liu Journal: J Med Genet Date: 2002-08 Impact factor: 6.318
Authors: Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo Journal: Genome Res Date: 2010-07-19 Impact factor: 9.043
Authors: A Eliot Shearer; E Ann Black-Ziegelbein; Michael S Hildebrand; Robert W Eppsteiner; Harini Ravi; Swati Joshi; Angelica C Guiffre; Christina M Sloan; Scott Happe; Susanna D Howard; Barbara Novak; Adam P Deluca; Kyle R Taylor; Todd E Scheetz; Terry A Braun; Thomas L Casavant; William J Kimberling; Emily M Leproust; Richard J H Smith Journal: J Med Genet Date: 2013-06-26 Impact factor: 6.318
Authors: Rachel T Morton-Jones; Srdjan M Vlajkovic; Peter R Thorne; Debra A Cockayne; Allen F Ryan; Gary D Housley Journal: Purinergic Signal Date: 2015-10-01 Impact factor: 3.765
Authors: Joaquin E Jimenez; Aida Nourbakhsh; Brett Colbert; Rahul Mittal; Denise Yan; Carlos L Green; Eric Nisenbaum; George Liu; Nicole Bencie; Jason Rudman; Susan H Blanton; Xue Zhong Liu Journal: Gene Date: 2020-04-15 Impact factor: 3.688
Authors: Zhihui Fong; Caoimhín S Griffin; Roddy J Large; Mark A Hollywood; Keith D Thornbury; Gerard P Sergeant Journal: Proc Natl Acad Sci U S A Date: 2021-09-14 Impact factor: 11.205